NYSE: RKT) to Acquire Redfin (NASDAQ: RDFN) in $1.75B Deal - More Stocks to Watch Inside!" src="https://www.abnewswire.com/upload/2025/03/1741618069.jpg" alt="Rocket Companies (NYSE: RKT) to Acquire Redfin (NASDAQ: RDFN) in $1.75B Deal - More Stocks to Watch Inside!" width="225" height="225">Rocket Companies (NYSE: RKT) is set to acquire Redfin (NASDAQ: RDFN) in an all-stock deal valued at $1.75 billion ($12.50 per share), integrating Redfin’s 50 million monthly visitors with Rocket’s mortgage offerings. The fintech giant will collapse its "Up-C" structure and issue a special $0.80 per share dividend for Class A common stock, payable on April 3. Rocket will host a conference call today at 8:00 a.m. ET to discuss the acquisition.
Power Metallic Mines Inc. (TSXV: PNPN)(OTCBB: PNPNF) ranked #4 on the TSX and #1 among mining stocks, recently rebranded from Power Nickel Inc. to emphasize its focus on metallic minerals exploration. The company secured C$50 million in private placement funding on February 27, 2025, to accelerate exploration and acquisitions. Over the past week, PNPN.V surged 5.63% to C$1.69, while PNPNF gained 3.76% to $1.20, reflecting strong market confidence. These milestones position Power Metallic Mines Inc. as a leading force in the mining sector.
AtlasClear Holdings (NYSEAMEX: ATCH) continues advancing its technology-driven financial services platform, focusing on trading, clearing, settlement, and banking for small and mid-market firms. In its March 3, 2025 update, the company reported that 10% of its debt has been satisfied through conversions, with $7.54 million in convertible debt settled, equating to 50% of the original Despac convertible debt and over 22% of total debt.
Checkpoint Therapeutics (NASDAQ: CKPT) is set to be acquired by Sun Pharma in a $355 million cash deal, offering $4.10 per share upfront with a contingent value right of up to $0.70 per share upon milestone achievement. The acquisition brings UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma (cSCC), under Sun Pharma’s global onco-derm franchise. Checkpoint’s breakthrough immunotherapy will now leverage Sun Pharma’s global reach, ensuring faster patient access and expanding CKPT’s innovation in targeted oncology treatments. Stockholder approval is pending.
Peraso Inc. (NASDAQ: PRSO), a leader in mmWave wireless technology, recently featured its CEO, Ron Glibbery, on 'The Street Reports Podcast' to discuss advancements in 60 GHz mmWave solutions, including applications in fixed wireless access, AI-driven connectivity, and military communications. The company's technology offers high-bandwidth, low-latency communications with features like adaptive beamforming and narrow "pencil" beams, enhancing stealth capabilities essential for military operations. These developments highlight Peraso's commitment to delivering innovative solutions across various sectors.
Market Trends and March 2025 Watchlist: As major industries undergo transformational shifts, these companies are making bold moves to expand market share, secure strategic acquisitions, and enhance technological innovation. Investors will be closely watching how Rocket Companies navigates its Redfin acquisition, Power Metallic Mines executes its expansion strategy, and Peraso Inc. advances its mi litary-grade wireless solutions. With key corporate milestones and stock performance trends in motion, these stocks remain ones to watch in the weeks ahead.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com